- Home
- MIRM vs KGS Comparison
MIRM vs KGS Comparison
Compare MIRM & KGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MIRM | KGS |
|---|---|---|
| Founded | 2018 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.7B | 6.7B |
| IPO Year | 2019 | 2023 |
Fundamental Metrics
Financial Performance| Metric | MIRM | KGS |
|---|---|---|
| Price | $107.23 | $68.69 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 7 |
| Target Price | ★ $119.85 | $57.17 |
| AVG Volume (30 Days) | 637.7K | ★ 1.4M |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 2.93% |
| EPS Growth | ★ 74.59 | 58.93 |
| EPS | N/A | ★ 0.20 |
| Revenue | $19,138,000.00 | ★ $1,308,100,000.00 |
| Revenue This Year | $26.22 | $12.30 |
| Revenue Next Year | $22.04 | $7.96 |
| P/E Ratio | ★ N/A | $343.60 |
| Revenue Growth | N/A | ★ 12.83 |
| 52 Week Low | $47.89 | $30.06 |
| 52 Week High | $114.99 | $77.68 |
Technical Indicators
Market Signals| Indicator | MIRM | KGS |
|---|---|---|
| Relative Strength Index (RSI) | 64.97 | 52.28 |
| Support Level | $87.93 | $64.82 |
| Resistance Level | $107.51 | $77.18 |
| Average True Range (ATR) | 4.13 | 2.32 |
| MACD | 1.17 | -0.09 |
| Stochastic Oscillator | 96.61 | 79.42 |
Price Performance
Historical ComparisonAbout MIRM Mirum Pharmaceuticals Inc.
Mirum Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing therapies for rare and orphan diseases. Its main product, Livmarli (maralixibat), is an orally administered IBAT inhibitor approved to treat cholestatic pruritus in patients with Alagille syndrome. The company is also developing treatments such as maralixibat for PFIC and ALGS, and volixibat for adult cholestatic liver diseases. Mirum currently has three approved medicines: Livmarli, Cholbam, and Ctexli.
About KGS Kodiak Gas Services Inc.
Kodiak Gas Services Inc is an operator of contract compression infrastructure in the United States. The company manages its business through two operating segments: Contract Services and Other Services. Contract Services consists of operating company-owned and customer-owned compression, gas treating, and cooling infrastructure, pursuant to fixed-revenue contracts to enable the production and gathering of natural gas and oil. Other Services consist of a full range of contract services to support the ancillary needs of customers, including station construction, maintenance and overhaul, freight and crane charges, and other time and material-based offerings. Maximum revenue for the company is generated from its Contract Services segment.